US health officials said on Friday the government's free COVID-19 test delivery programs would reopen in late September, in time for the holiday season,...
While the world grappled with the unprecedented challenges of the COVID-19 pandemic, cinema offered a unique lens through which to process and understand the...
The US health regulator has changed its strain recommendation for the 2024-25 COVID-19 vaccines, as it asked manufacturers to update the new shots to...
A newly released study does not say COVID-19 vaccines may have fuelled excess deaths across the world, contrary to claims on social media.
The journal...
A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according to a study by Stanford University researchers.
Currently,...
The so-called FLiRT variants of SARS-CoV-2 coronavirus that cause COVID-19 have been the dominant forms of the virus circulating this year globally, according...
AstraZeneca's COVID-19 prevention therapy reduced the risk of infection in patients with weaker immunity in a late-stage trial, meeting its primary goal, the...
The globalised world is consistently experiencing breakouts of viruses of various kinds and shapes that affect the people to varying degree. Since many years...
LONDON: British former prime minister Boris Johnson gave his most explicit apology for his handling of the coronavirus crisis on Wednesday, saying his government...
Novavax's updated vaccine has been granted emergency-use authorization by the World Health Organization (WHO) for active immunization to prevent COVID-19 in individuals aged 12...
In a new paper published in the journal Viruses, research team from United States' University of California Riverside described an important discovery. The protein...
The US Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant...
UK Health Security Agency (UKSHA) said on Friday that 34 COVID-19 cases linked to the highly mutated variant BA.2.86 had been identified in England.
The...
Moderna on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus...
Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the "Eris" and "Fornax" subvariants in humans.
The...